[go: up one dir, main page]

NO924803D0 - Tumor-relatert monoklonalt antistoff 88bv59 - Google Patents

Tumor-relatert monoklonalt antistoff 88bv59

Info

Publication number
NO924803D0
NO924803D0 NO924803A NO924803A NO924803D0 NO 924803 D0 NO924803 D0 NO 924803D0 NO 924803 A NO924803 A NO 924803A NO 924803 A NO924803 A NO 924803A NO 924803 D0 NO924803 D0 NO 924803D0
Authority
NO
Norway
Prior art keywords
tumor
monoclonal antibody
related monoclonal
antibody
monoclonal
Prior art date
Application number
NO924803A
Other languages
English (en)
Other versions
NO924803L (no
Inventor
Martin Victor Haspel
Barry Jay Kobrin
Virginia Zewe Crichton
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NO924803D0 publication Critical patent/NO924803D0/no
Publication of NO924803L publication Critical patent/NO924803L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO92924803A 1991-12-13 1992-12-11 Tumor-relatert monoklonalt antistoff 88bv59 NO924803L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80730091A 1991-12-13 1991-12-13

Publications (2)

Publication Number Publication Date
NO924803D0 true NO924803D0 (no) 1992-12-11
NO924803L NO924803L (no) 1993-06-14

Family

ID=25196057

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924803A NO924803L (no) 1991-12-13 1992-12-11 Tumor-relatert monoklonalt antistoff 88bv59

Country Status (12)

Country Link
EP (1) EP0546634A3 (no)
JP (1) JP3539985B2 (no)
KR (1) KR930013103A (no)
AU (1) AU651261B2 (no)
CA (1) CA2083542A1 (no)
FI (1) FI925638A7 (no)
HU (1) HU218081B (no)
IL (1) IL103758A (no)
NO (1) NO924803L (no)
NZ (1) NZ245443A (no)
TW (1) TW271450B (no)
ZA (1) ZA928880B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ521182A (en) 2000-03-03 2004-11-26 Cambridge Antibody Tech Human antibodies against eotaxin comprising VH adn VL domains and their use
US6946546B2 (en) 2000-03-06 2005-09-20 Cambridge Antibody Technology Limited Human antibodies against eotaxin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4322879A (en) * 1978-01-11 1979-07-19 Massachusetts General Hospital, The Producing antibodies
US4172124A (en) 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4997762A (en) 1984-01-31 1991-03-05 Akzo N.V. Tumor associated monocoloal antibodies derived from human B-cell line
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
US4828991A (en) 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
DE3855280T2 (de) * 1987-07-02 1996-09-19 Akzo Nv Von mca 16-88 erkanntes antigen

Also Published As

Publication number Publication date
IL103758A (en) 1998-07-15
JP3539985B2 (ja) 2004-07-07
HU9203932D0 (en) 1993-04-28
KR930013103A (ko) 1993-07-21
JPH05317042A (ja) 1993-12-03
FI925638L (fi) 1993-06-14
TW271450B (no) 1996-03-01
HU218081B (hu) 2000-05-28
NO924803L (no) 1993-06-14
NZ245443A (en) 1995-12-21
AU3008892A (en) 1993-06-17
CA2083542A1 (en) 1993-06-14
ZA928880B (en) 1993-08-12
FI925638A0 (fi) 1992-12-11
FI925638A7 (fi) 1993-06-14
IL103758A0 (en) 1993-04-04
HUT65480A (en) 1994-06-28
AU651261B2 (en) 1994-07-14
EP0546634A3 (en) 1994-09-21
EP0546634A2 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
CY2006001I2 (el) Ανθρωποποιημενο heregulin αντισωμα
DE69225757D1 (de) Lyophilische monoklonale antikörperpräparationen
DK666389D0 (da) Monoklonalt antistof
FI940144L (fi) Vasta-aineiden tuotanto
FI930580L (fi) Tri- och tetravalensiska monopecifika antigen bindande proteiner
DK145493D0 (da) Antistof
DE68914244D1 (de) Monoklonaler Antikörper.
FI935970L (fi) Tumoer/kolhydratantigenspecifik monoklonal antikropp samt cellinje
EP0580859A4 (en) Anti-eda monoclonal antibody
NO920523D0 (no) Ige-reseptor-antistoff
FI895287A7 (fi) Fukosyylikeramidin vastainen monoklonaalinen vasta-aine
EP0506523A3 (en) Monoclonal antibodies
GB9204928D0 (en) Monoclonal antibody production
DK49291A (da) Gramnegativ-bakterieendotoxinblokerende, monoklonale antistoffer
NO890116D0 (no) Monoklonale antistoffer.
FI931581A7 (fi) Immunanalys, monoklonal antikropp och hybridom
DK474189A (da) Monoklonalt antistof
NO924803D0 (no) Tumor-relatert monoklonalt antistoff 88bv59
ITMI910491A0 (it) Immonotossina da anticorpi monoclonali anti-cds
DE69023717D1 (de) Monoklonaler Antikörper.
DK370089D0 (da) Anti-urokinase monoklonale antistoffer
DK413389A (da) Monoklonale antistoffer
FI935038A7 (fi) Kasvaimiin liittyvä monoklonaalinen vasta-aine 81AV78
DE69427850D1 (de) Monoklonaler antikörper gegen mucoglykoprotein
ITMI910660A0 (it) Anticorpi monoclonali come antidoti

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application